This week a clinical trial was announced that will enroll mesothelioma patients to be treated with an agent called antineoplaston.

This therapy is based on a group of molecules discovered by Dr. Stanislaw Burzynski and are considered alternative therapy and outside the mainstream. These molecules ...




This article is courtesy of Mesothelioma Research and Information

Add to Google